|
|
||||||||
The Journal of Immunology, Vol 155, Issue 7 3578-3584, Copyright © 1995 by American Association of Immunologists
ARTICLES |
DM Meyer, ML Dustin and CP Carron
Department of Immunology, Monsanto Company, St. Louis, MO 63198, USA.
Intercellular adhesion molecule-1 (ICAM-1) is a member of the Ig superfamily, contains five Ig-like domains comprising the extracellular portion of the molecule, and interacts with lymphocyte function- associated molecule-1 (LFA-1), a member of the beta 2-integrin family. LFA-1/ICAM-1 interaction is important in a variety of cellular events including Ag-specific T cell activation and leukocyte transendothelial migration. Recently, a soluble circulating form of ICAM-1 has been detected in human serum that appears to result from the proteolytic cleavage of membrane ICAM-1. Native and recombinant soluble forms of ICAM-1 have been reported to inhibit LFA-1/ICAM-mediated adhesion in vitro, and it is conceivable that circulating forms of soluble ICAM-1 are regulators of LFA-1/ICAM-1-mediated cell-cell interaction in vivo. We have investigated the properties of the ICAM-1 ectodomain (sICAM453) as an inhibitor of LFA-1 interaction with ICAM-1 in cell- and molecule- based systems. The results show clearly that recombinant sICAM453 can inhibit LFA-1/ICAM-1 interaction. Soluble ICAM-1 inhibited LFA-1- mediated cell adhesion to immobilized sICAM453 and homotypic T-cell aggregation with IC50 in the 20 to 40 microM range. Definitive evidence that sICAM-1 can inhibit LFA-1 interaction with ICAM-1 was obtained by showing that the sICAM-1 inhibited the interaction between LFA-1 protein micelles and ICAM-1 immobilized on plastic. These results clearly show that sICAM453 can bind to LFA-1 and competitively inhibit ICAM-1/LFA-1-mediated cell-cell interaction, albeit at concentrations much greater than found in plasma. As a consequence, it is unlikely that sICAM-1 would antagonize ICAM-1/LFA-1-mediated cellular events in vivo.
This article has been cited by other articles:
![]() |
V. I. Otto, E. Damoc, L. N. Cueni, T. Schurpf, R. Frei, S. Ali, N. Callewaert, A. Moise, J. A. Leary, G. Folkers, et al. N-Glycan structures and N-glycosylation sites of mouse soluble intercellular adhesion molecule-1 revealed by MALDI-TOF and FTICR mass spectrometry Glycobiology, November 1, 2006; 16(11): 1033 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sonnet, P. Lafuste, L. Arnold, M. Brigitte, F. Poron, F. Authier, F. Chretien, R. K. Gherardi, and B. Chazaud Human macrophages rescue myoblasts and myotubes from apoptosis through a set of adhesion molecular systems J. Cell Sci., June 15, 2006; 119(12): 2497 - 2507. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Angelov, P. Guillaume, M. Cebecauer, G. Bosshard, D. Dojcinovic, P. Baumgaertner, and I. F. Luescher Soluble MHC-Peptide Complexes Containing Long Rigid Linkers Abolish CTL-Mediated Cytotoxicity J. Immunol., March 15, 2006; 176(6): 3356 - 3365. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. I. Otto, T. Schurpf, G. Folkers, and R. D. Cummings Sialylated Complex-type N-Glycans Enhance the Signaling Activity of Soluble Intercellular Adhesion Molecule-1 in Mouse Astrocytes J. Biol. Chem., August 20, 2004; 279(34): 35201 - 35209. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Steff, D. Gagne, M. Page, P. Hugo, and D. Gosselin Concentration of soluble intercellular adhesion molecule-1 in serum samples from patients with endometriosis collected during the luteal phase of the menstrual cycle Hum. Reprod., January 1, 2004; 19(1): 172 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weis, C. L. Schlichting, E. G. Engleman, and J. P. Cooke Endothelial Determinants of Dendritic Cell Adhesion and Migration: New Implications for Vascular Diseases Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1817 - 1823. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.M. Mackler, L.M. Green, P.J. McMillan, and S.M. Yellon Distribution and Activation of Uterine Mononuclear Phagocytes in Peripartum Endometrium and Myometrium of the Mouse Biol Reprod, May 1, 2000; 62(5): 1193 - 1200. [Abstract] [Full Text] |
||||
![]() |
P. VIGANỎ, E. SOMIGLIANA, B. GAFFURI, R. SANTORSOLA, M. BUSACCA, and M. VIGNALI Endometrial Release of Soluble Intercellular Adhesion Molecule 1 and Endometriosis: Relationship to the Extent of the Disease Obstet. Gynecol., January 1, 2000; 95(1): 115 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kusterer, J. Bojunga, M. Enghofer, E. Heidenthal, K. H. Usadel, H. Kolb, and S. Martin Soluble ICAM-1 reduces leukocyte adhesion to vascular endothelium in ischemia-reperfusion injury in mice Am J Physiol Gastrointest Liver Physiol, August 1, 1998; 275(2): G377 - G380. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kurkijarvi, D. H. Adams, R. Leino, T. Mottonen, S. Jalkanen, and M. Salmi Circulating Form of Human Vascular Adhesion Protein-1 (VAP-1): Increased Serum Levels in Inflammatory Liver Diseases J. Immunol., August 1, 1998; 161(3): 1549 - 1557. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |